Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium.
Tseng
Kuan-Chiao
KC
Hwang
Tzung-Jeng
TJ
D000328:Adult; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005440:Fluid Therapy; D006801:Humans; D018020:Lithium Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000628:therapy; D013997:Time Factors
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D003024:Clozapine